160 related articles for article (PubMed ID: 23891508)
21. The variation of CD4+CD25+ regulatory T cells in the periphery blood and tumor microenvironment of non-small cell lung cancer patients and the downregulation effects induced by CpG ODN.
Wang YY; He XY; Cai YY; Wang ZJ; Lu SH
Target Oncol; 2011 Sep; 6(3):147-54. PubMed ID: 21611754
[TBL] [Abstract][Full Text] [Related]
22. Distribution of Regulatory T-Cells and Other Phenotypes of T-Cells in Tumors and Regional Lymph Nodes of Colorectal Cancer Patients.
Kazama K; Otake J; Satoyoshi T; Shiozawa M; Sugano N; Sato S; Atsumi Y; Kano K; Murakawa M; Maezawa Y; Hashimoto I; Numata M; Oshima T; Yukawa N; Rino Y; Sasada T; Masuda M
In Vivo; 2020; 34(2):849-856. PubMed ID: 32111794
[TBL] [Abstract][Full Text] [Related]
23. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
[TBL] [Abstract][Full Text] [Related]
24. Effects of interleukin-12 on in vitro culture with interleukin-2 of regional lymph node lymphocytes from lung cancer patients.
Hanagiri T; Takenoyama M; Yoshimatsu T; Hirashima C; Yoshino I; Nakanishi K; Nagashima A; Nomoto K; Yasumoto K
Cancer Immunol Immunother; 1996 Oct; 43(2):87-93. PubMed ID: 8954142
[TBL] [Abstract][Full Text] [Related]
25. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
[TBL] [Abstract][Full Text] [Related]
26. Preferential expansion of pro-inflammatory Tregs in human non-small cell lung cancer.
Phillips JD; Knab LM; Blatner NR; Haghi L; DeCamp MM; Meyerson SL; Heiferman MJ; Heiferman JR; Gounari F; Bentrem DJ; Khazaie K
Cancer Immunol Immunother; 2015 Sep; 64(9):1185-91. PubMed ID: 26047578
[TBL] [Abstract][Full Text] [Related]
27. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
28. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
[TBL] [Abstract][Full Text] [Related]
29. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC).
Erfani N; Mehrabadi SM; Ghayumi MA; Haghshenas MR; Mojtahedi Z; Ghaderi A; Amani D
Lung Cancer; 2012 Aug; 77(2):306-11. PubMed ID: 22608141
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors in patients with pathologic T1-2N1M0 disease in non-small cell carcinoma of the lung.
Matsuoka K; Sumitomo S; Misaki N
J Thorac Oncol; 2007 Dec; 2(12):1098-102. PubMed ID: 18090581
[TBL] [Abstract][Full Text] [Related]
31. Lymph node ratio as a prognostic factor in patients with pathological N2 non-small cell lung cancer.
Tamura M; Matsumoto I; Saito D; Yoshida S; Takata M; Takemura H
World J Surg Oncol; 2016 Nov; 14(1):295. PubMed ID: 27884195
[TBL] [Abstract][Full Text] [Related]
32. Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma.
Müller S; Poehnert D; Müller JA; Scheumann GW; Koch M; Lück R
World J Surg; 2010 Jul; 34(7):1481-7. PubMed ID: 20162276
[TBL] [Abstract][Full Text] [Related]
33. CD83(+) dendritic cells and Foxp3(+) regulatory T cells in primary lesions and regional lymph nodes are inversely correlated with prognosis of gastric cancer.
Kashimura S; Saze Z; Terashima M; Soeta N; Ohtani S; Osuka F; Kogure M; Gotoh M
Gastric Cancer; 2012 Apr; 15(2):144-53. PubMed ID: 22083420
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Implications of Heterogeneity in Intra-tumoral Immune Composition for Recurrence in Early Stage Lung Cancer.
Mony JT; Schuchert MJ
Front Immunol; 2018; 9():2298. PubMed ID: 30374348
[No Abstract] [Full Text] [Related]
35. Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients.
Kotsakis A; Koinis F; Katsarou A; Gioulbasani M; Aggouraki D; Kentepozidis N; Georgoulias V; Vetsika EK
Sci Rep; 2016 Dec; 6():39247. PubMed ID: 27976733
[TBL] [Abstract][Full Text] [Related]
36. Expression of TNFR2 by regulatory T cells in peripheral blood is correlated with clinical pathology of lung cancer patients.
Yan F; Du R; Wei F; Zhao H; Yu J; Wang C; Zhan Z; Ding T; Ren X; Chen X; Li H
Cancer Immunol Immunother; 2015 Nov; 64(11):1475-85. PubMed ID: 26280204
[TBL] [Abstract][Full Text] [Related]
37. Frequency and prognostic significance of preoperatively detected enlarged regional lymph nodes in patients with pathological stage I non-small cell lung cancer following resection.
Hoang JK; Patz E; Giroux D; Goldstraw P
J Thorac Oncol; 2007 Dec; 2(12):1103-6. PubMed ID: 18090582
[TBL] [Abstract][Full Text] [Related]
38. Disturbed Th17/Treg Balance in Patients with Non-small Cell Lung Cancer.
Duan MC; Han W; Jin PW; Wei YP; Wei Q; Zhang LM; Li JC
Inflammation; 2015 Dec; 38(6):2156-65. PubMed ID: 26077695
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer.
Saji H; Tsuboi M; Yoshida K; Kato Y; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
J Thorac Oncol; 2011 Nov; 6(11):1865-71. PubMed ID: 21964529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]